On February 12, 2016, the Board of Directors of GlyEco, Inc. appointed Ian Rhodes to be the company's Chief Financial Officer and Grant Sahag to be the company's President, effective February 22, 2016. Mr. Rhodes, previously served as the Chief Financial Officer of Calmare Therapeutics Incorporated. from 2014 to 2016.

As Chief Financial Officer, Mr. Rhodes was responsible for all financial and accounting matters, including SEC reporting. From 2012 to 2014, Mr. Rhodes served as an independent consultant and entrepreneur, and his activities included leading an investor /management group in assessing a potential multi-location franchised food concept. Mr. Sahag, previously served as Executive Vice President and Chief Information Officer of the company.

Prior to being named as Executive Vice President and Chief Information Officer, Mr. Sahag served as Senior VP Business Development and VP International Development. Before joining the company, Mr. Sahag was a business attorney who specialized in providing strategic business development advice to emerging growth companies.